ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AE07 | B | Dabigatran etexilate (mesilate) - 75mg | 5314 | 221303/08 | PRADAXA | 75mg | 60 | Capsule, hard | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 6,954,385 L.L | 23.08 | B | Boehringer Ingelheim International GmbH | Germany | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B01AE07 | B | Dabigatran etexilate (mesilate) - 75mg | 5317 | 221304/08 | PRADAXA | 75mg | 30 | Capsule, hard | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 3,695,567 L.L | 23.08 | B | Boehringer Ingelheim International GmbH | Germany | 2/5/2024 | 0 |